Literature DB >> 24751477

Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia.

Outi K Laine1, Sirpa M Koskela, Tuula K Outinen, Lotta Joutsi-Korhonen, Heini Huhtala, Antti Vaheri, Mikko A Hurme, Juulia Jylhävä, Satu M Mäkelä, Jukka T Mustonen.   

Abstract

Thrombocytopenia and altered coagulation characterize all hantavirus infections. To further assess the newly discovered predictive biomarkers of disease severity during acute Puumala virus (PUUV) infection, we studied the associations between them and the variables reflecting coagulation, fibrinolysis and endothelial activation. Nineteen hospital-treated patients with serologically confirmed acute PUUV infection were included. Acutely, plasma levels of pentraxin-3 (PTX3), cell-free DNA (cf-DNA), complement components SC5b-9 and C3 and interleukin-6 (IL-6) were recorded as well as platelet ligands and markers of coagulation and fibrinolysis. High values of plasma PTX3 associated with thrombin formation (prothrombin fragments F1+2; r = 0.46, P = 0.05), consumption of platelet ligand fibrinogen (r = -0.70, P < 0.001) and natural anticoagulants antithrombin (AT) (r = -0.74, P < 0.001), protein C (r = -0.77, P < 0.001) and protein S free antigen (r = -0.81, P < 0.001) and a decreased endothelial marker ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 domain 13) (r = -0.48, P = 0.04). Plasma level of AT associated with C3 (r = 0.76, P < 0.001), IL-6 (r = -0.56, P = 0.01) and cf-DNA (r = -0.47, P = 0.04). High cf-DNA coincided with increased prothrombin fragments F1+2 (r = 0.47, P = 0.04). Low C3 levels reflecting the activation of complement system through the alternative route predicted loss of all natural anticoagulants (for protein C r = 0.53, P = 0.03 and for protein S free antigen r = 0.64, P = 0.004). Variables depicting altered coagulation follow the new predictive biomarkers of disease severity, especially PTX3, in acute PUUV infection. The findings are consistent with the previous observations of these biomarkers also being predictive for low platelet count and underline the cross-talk of inflammation and coagulation systems in acute PUUV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24751477     DOI: 10.1097/MBC.0000000000000117

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  9 in total

1.  Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.

Authors:  Marco Goeijenbier; Joost C M Meijers; Fatih Anfasa; Jeroen M Roose; Cornelia A M van de Weg; Kamran Bakhtiari; Heikki Henttonen; Antti Vaheri; Albert D M E Osterhaus; Eric C M van Gorp; Byron E E Martina
Journal:  Front Microbiol       Date:  2015-03-24       Impact factor: 5.640

2.  The fundamental role of endothelial cells in hantavirus pathogenesis.

Authors:  Jussi Hepojoki; Antti Vaheri; Tomas Strandin
Journal:  Front Microbiol       Date:  2014-12-22       Impact factor: 5.640

3.  Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner.

Authors:  Svetlana F Khaiboullina; Sergey P Morzunov; Stephen C St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

4.  High plasma resistin associates with severe acute kidney injury in Puumala hantavirus infection.

Authors:  Paula S Mantula; Tuula K Outinen; Pia Jaatinen; Mari Hämäläinen; Heini Huhtala; Ilkka H Pörsti; Antti Vaheri; Jukka T Mustonen; Satu M Mäkelä
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

5.  Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients.

Authors:  Susanne Feder; Elisabeth M Haberl; Marlen Spirk; Thomas S Weiss; Reiner Wiest; Christa Buechler
Journal:  Clin Exp Med       Date:  2020-02-20       Impact factor: 3.984

6.  Predictive value of pentraxin-3 on disease severity and mortality risk in patients with hemorrhagic fever with renal syndrome.

Authors:  Hong Du; Haifeng Hu; Pingzhong Wang; Xiaoyan Wang; Ying Zhang; Hong Jiang; Jing Li; Xuefan Bai; Jianqi Lian
Journal:  BMC Infect Dis       Date:  2021-05-17       Impact factor: 3.090

Review 7.  Coagulopathy in Acute Puumala Hantavirus Infection.

Authors:  Sirpa Koskela; Satu Mäkelä; Tomas Strandin; Antti Vaheri; Tuula Outinen; Lotta Joutsi-Korhonen; Ilkka Pörsti; Jukka Mustonen; Outi Laine
Journal:  Viruses       Date:  2021-08-06       Impact factor: 5.048

8.  Serum Markers Associated with Disease Severity in a Bosnian Hemorrhagic Fever with Renal Syndrome Cohort.

Authors:  Danny Noack; Maja Travar; Visnja Mrdjen; Jolanda J C Voermans; David van de Vijver; Richard Molenkamp; Marion P G Koopmans; Marco Goeijenbier; Barry Rockx
Journal:  Viruses       Date:  2022-06-24       Impact factor: 5.818

Review 9.  Severity Biomarkers in Puumala Hantavirus Infection.

Authors:  Tuula K Outinen; Satu Mäkelä; Ilkka Pörsti; Antti Vaheri; Jukka Mustonen
Journal:  Viruses       Date:  2021-12-28       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.